Clinically, patients with chronic pain have higher risks of cognitive decline and exhibit biomarker changes (e.g., elevated tau, amyloid, and microglial markers) suggestive of an accelerated neurodegenerative process. This evidence concerns the gene MAPT and Mental deterioration.